Kala Pharmaceuticals diskutieren
Kala Pharmaceuticals Inc.
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
6,06 €
-0,90 %
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Neueste Beiträge
Truist_Financial_Co_ in Curis Inc. diskutieren